Organon & Co. Common Stock

Financials

Panoramica Estratto Conto Statistiche Dividendi

Flusso di cassa derivante dalle attività operative 2.46 B858 M799 M939 M700 M 850 M Flussi di cassa derivanti dalle attività di investimento -481 M-420 M-260 M-513 M-390 M 168 M Liquidità derivante dalle attività di finanziamento -1.33 B-433 M-569 M-368 M-561 M -524 M Liquidità libera 2.07 B538 M546 M939 M414 M 614 M

Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

OGN

Financials

Organon & Co. Common Stock

Notizie

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know

Il titolo azionario di Organon & Co raggiunge il massimo a 52 settimane a $13,44

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Il titolo azionario di Organon & Co raggiunge il massimo a 52 settimane a 13,4 USD

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It

An April To Remember For Stocks

Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Organon (OGN) Q1 Earnings and Revenues Miss Estimates

Organon non raggiunge le stime con ricavi in calo del 9%

Le azioni di Organon & Co raggiungono il massimo di 52 settimane a 13,25 USD

Company News for Apr 28, 2026

Nasdaq Futures Slip as AI Concerns Resurface, FOMC Meeting and Earnings in Focus